We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 980

2013 year-end Foreign Corrupt Practices Act update
  • Baker & Hostetler LLP
  • Libya, USA
  • February 10 2014

The third and fourth quarters of 2013 proved to be eventful and poten- tially prophetic as to the course the Foreign Corrupt Practices Act ("FCPA"

Why agency fraud is like fraud on the FDA
  • Dechert LLP
  • USA
  • February 17 2012

In our rather terse (due to firm involvement) post on Monday concerning Merck & Co. v. Ratliff, ___ S.W.3d ___, 2012 WL 413522 (Ky. App. Feb. 10, 2012) beating both BNA and 360 by two days, BTW we mentioned the “interesting” aspects of that case

Two recent false claims decisions issued by the federal courts
  • Bricker & Eckler LLP
  • USA
  • May 25 2011

On May 16, 2011, the U.S. Supreme Court ruled that False Claims Act (FCA) cases brought by whistleblowers who base their allegations on information found in records released by federal agencies pursuant to a Freedom of Information Act (FOIA) request are subject to the “public disclosure” bar

Supreme Court holds that issuers can be liable for omitting material facts from statements of opinion in Omnicare case
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • March 25 2015

In its opinion in Omnicare, Inc. v. Laborers District Council Construction Industry Pension Fund, released yesterday, the U.S. Supreme Court held

Genzyme First Circuit decision
  • Baker & Hostetler LLP
  • USA
  • June 13 2014

In a huge victory for Massachusetts-based biologics manufacturer Genzyme Corporation, the First Circuit Court of Appeals on June 5, 2014 affirmed the

White collar roundup - April 2014
  • Day Pitney LLP
  • USA
  • April 1 2014

In United States v. Gupta the U.S. Court of Appeals for the Second Circuit affirmed the conviction of Rajat Gupta for his participation in the Raj

Expect Focus Vol. 1, Winter 2015: trademarks in Cuba, successful whistleblowers, big data, health care encryption, jury instruction tips
  • Carlton Fields Jorden Burt
  • USA
  • March 25 2015

New Jersey’s new data privacy standard, signed into law as S. 562 by Gov. Chris Christie on January 9, requires health insurance carriers that are

Dechert survey of securities fraud class actions brought against U.S. life sciences companies
  • Dechert LLP
  • USA
  • March 16 2015

The past year was particularly noteworthy with respect to the relative number of securities fraud class action lawsuits brought against publicly

FCPA anti-corruption developments: 2012 end of summer round-up
  • Morrison & Foerster LLP
  • China, France, Global, Haiti, India, Mexico, United Kingdom, USA
  • October 10 2012

While the temperatures rose this summer, the number of Foreign Corrupt Practices Act enforcement actions seems to have cooled off for the first time in the last five years

Last man standing
  • Cooley LLP
  • USA
  • December 27 2013

The Gentiva securities class action is based on allegations that the company violated Medicare rules and artificially inflated the Medicare payments